OTCMKTS:CRLBF

Cresco Labs - CRLBF Stock Forecast, Price & News

$3.32

-0.08 (-2.35%)

(As of 11/25/2022 08:58 PM ET)

Add

Compare

Today's Range: $3.16
▼
$3.42
50-Day Range: $2.44
▼
$3.52
52-Week Range: $2.39
▼
$9.07

Volume: 265,900 shs
Average Volume: 507,755 shs
Market Capitalization: $896.51 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $8.80

Cresco Labs MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 165.1% Upside
$8.80 Price Target
Short Interest: Healthy
0.52% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.22
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.13) to $0.04 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.90 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Cresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $8.80, Cresco Labs has a forecasted upside of 165.1% from its current price of $3.32.
Amount of Analyst Coverage
Cresco Labs has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.52% of the outstanding shares of Cresco Labs have been sold short.
Short Interest Ratio / Days to Cover
Cresco Labs has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cresco Labs has recently increased by 8.30%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Cresco Labs does not currently pay a dividend.
Dividend Growth
Cresco Labs does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CRLBF.

2.3

News and Social Media Coverage

News Sentiment
Cresco Labs has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Cresco Labs this week, compared to 2 articles on an average week.
Social Mentions This Week
MarketBeat has tracked 3 reddit mentions for Cresco Labs this week, compared to 0 mentions on an average week.
Search Interest
11 people have searched for CRLBF on MarketBeat in the last 30 days. This is an increase of 120% compared to the previous 30 days.
MarketBeat Follows
Only 14 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -26% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cresco Labs insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.26% of the stock of Cresco Labs is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Cresco Labs are expected to grow in the coming year, from ($0.13) to $0.04 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cresco Labs is -13.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cresco Labs is -13.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cresco Labs has a P/B Ratio of 1.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Cresco Labs (OTCMKTS:CRLBF) Stock

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of January 27, 2022, it owned and operated 48 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.

Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

CRLBF Stock News Headlines

November 23, 2022 | marketbeat.com

Three CBD Stocks to Dominate a Budding Industry (CRLBF)

The CBD industry is growing at a high 20% CAGR and is expected to more than triple in size over the next 6 to 7 years, that's a budding opportunity.

November 27, 2022 | americanbankingnews.com

Head-To-Head Comparison: Cresco Labs (OTCMKTS:CRLBF) and Bon Natural Life (NYSE:BON)

November 22, 2022 | americanbankingnews.com

Q4 2022 Earnings Estimate for Cresco Labs Inc. Issued By Echelon Wealth Partners (OTCMKTS:CRLBF)

November 20, 2022 | americanbankingnews.com

FY2023 EPS Estimates for Cresco Labs Inc. (OTCMKTS:CRLBF) Decreased by Analyst

November 19, 2022 | nasdaq.com

Good Stocks To Buy Right Now? 3 Cannabis Stocks To Watch

November 16, 2022 | finance.yahoo.com

Marijuana industry descends upons Las Vegas for MJBizCon

November 15, 2022 | seekingalpha.com

Cresco Labs Inc. (CRLBF) Q3 2022 Earnings Call Transcript

November 15, 2022 | finance.yahoo.com

Canadian Securities Exchange Reports October 2022 Performance Figures

November 15, 2022 | markets.businessinsider.com

Cresco Labs Q3 Revenue Drops Slightly YoY, Cuts Net Loss

November 15, 2022 | finance.yahoo.com

Cresco Labs Announces Third Quarter 2022 Results

November 6, 2022 | seekingalpha.com

Cresco Labs Is Worth The Wait

November 4, 2022 | markets.businessinsider.com

EXCLUSIVE: Sean 'Diddy' Combs' Right-Hand Man Tarik Brooks Tells All, Why Combs Enterprises Is Getting Into Cannabis

November 4, 2022 | msn.com

Cresco Labs Gains 'Firm Visibility' With Recently Announced Asset Sales To Sean Diddy Combs

November 4, 2022 | seekingalpha.com

Cresco Labs: Assessing The Risks And Opportunities In The U.S. Cannabis Giant

November 4, 2022 | businesswire.com

Cresco Labs & Columbia Care Announce Planned Divestiture in Three Markets to Sean “Diddy” Combs, Creating the First Minority-Owned, Vertically Integrated Multi-State ...

November 4, 2022 | seekingalpha.com

Sean ‘Diddy’ Combs to buy cannabis assets from Cresco Labs and Columbia Care - WSJ

November 4, 2022 | finance.yahoo.com

Sean ‘Diddy’ Combs to Buy Cannabis Operations in New York, Two Other States for Up to $185 Million

November 4, 2022 | finance.yahoo.com

Cresco Labs & Columbia Care Announce Planned Divestiture in Three Markets to Sean "Diddy" Combs, Creating the First Minority-Owned, Vertically Integrated Multi-State Cannabis Operator

November 1, 2022 | finanznachrichten.de

Cresco Labs Announces Board Director Sidney Dillard's Resignation

November 1, 2022 | msn.com

Why Green Thumb Industries, Curaleaf, and Cresco Labs Were Soaring Today

October 27, 2022 | finance.yahoo.com

Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022

October 26, 2022 | msn.com

Cresco Labs Anticipates NYC's Massive Cannabis Demand With Strategic Move In Hudson Valley

October 25, 2022 | finance.yahoo.com

Cresco Labs Announces Board Director Sidney Dillard’s Resignation

October 18, 2022 | msn.com

Where To Buy Legal Weed These Days: Curaleaf, Cresco & Other Operators Launch Sales At New Locations

October 17, 2022 | finance.yahoo.com

Cresco Labs Opens Second Pensacola Florida Dispensary

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

CRLBF Company Calendar

Today: 11/27/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medicinals & botanicals
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:CRLBF
CUSIP: N/A
CIK: 1832928
Web: www.crescolabs.com
Phone: 312-929-0993
Fax: N/A
Employees: 3,500
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $8.80
High Stock Price Forecast: $15.00
Low Stock Price Forecast: $5.00
Forecasted Upside/Downside: +165.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.25)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-319,600,000.00
Net Margins: -7.60%
Pretax Margin: 4.83%
Return on Equity: -6.48%
Return on Assets: -2.88%

Debt

Debt-to-Equity Ratio: 0.81
Current Ratio: 1.31
Quick Ratio: 0.75

Sales & Book Value

Annual Sales: $821.68 million
Price / Sales: 1.09
Cash Flow: $0.12 per share
Price / Cash Flow: 28.85
Book Value: $2.94 per share
Price / Book: 1.13

Miscellaneous

Outstanding Shares: 270,033,000
Free Float: N/A
Market Cap: $896.51 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Thomas J. Manning (Age 65)
Exec. Chairman
Comp: $878.31k

Mr. Charles Bachtell (Age 43)
Co-Founder, CEO & Director
Comp: $1.25M

Mr. Robert M. Sampson (Age 47)
Co-Founder & Independent Director

Mr. Dennis M. Olis (Age 59)
Chief Financial Officer
Comp: $550k

Mr. Ty Gent (Age 63)
Chief Operating Officer

Ms. Brenna Albert CPA
Sr. VP and Controller of Accounting, Treasury & Tax

Mr. Zach Marburger (Age 37)
Interim Chief Information Officer

Jake Graves
Mang. of Investor Relations

Mr. John Schetz (Age 45)
Gen. Counsel

Ms. Impola Kelli
VP of Compliance

Key Competitors

View All Competitors

CRLBF Stock - Frequently Asked Questions

Should I buy or sell Cresco Labs stock right now?: 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CRLBF shares.
View CRLBF analyst ratings or view top-rated stocks.
What is Cresco Labs' stock price forecast for 2023?: 6 Wall Street research analysts have issued 12-month target prices for Cresco Labs' stock. Their CRLBF share price forecasts range from $5.00 to $15.00. On average, they expect the company's share price to reach $8.80 in the next year. This suggests a possible upside of 165.1% from the stock's current price.
View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts.
How have CRLBF shares performed in 2022?: Cresco Labs' stock was trading at $6.67 at the start of the year. Since then, CRLBF shares have decreased by 50.2% and is now trading at $3.32.
View the best growth stocks for 2022 here.
Are investors shorting Cresco Labs?: Cresco Labs saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 1,397,100 shares, an increase of 8.3% from the October 15th total of 1,290,000 shares. Based on an average daily trading volume, of 722,400 shares, the days-to-cover ratio is currently 1.9 days.
View Cresco Labs' Short Interest.

What is Cresco Labs' stock symbol?: Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."
How do I buy shares of Cresco Labs?: Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cresco Labs' stock price today?: One share of CRLBF stock can currently be purchased for approximately $3.32.
How much money does Cresco Labs make?: Cresco Labs (OTCMKTS:CRLBF) has a market capitalization of $896.51 million and generates $821.68 million in revenue each year. The company earns $-319,600,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis.
How many employees does Cresco Labs have?: The company employs 3,500 workers across the globe.
How can I contact Cresco Labs?: Cresco Labs' mailing address is 400 West Erie Street, Chicago, IL 60654. The official website for the company is www.crescolabs.com. The company can be reached via phone at 312-929-0993 or via email at investors@crescolabs.com.

This page (OTCMKTS:CRLBF) was last updated on 11/28/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cresco Labs - CRLBF Stock Forecast, Price & News

Cresco Labs MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month